|
NARI | Inari Medical, Inc. |
|
|
NARI | Inari Medical, Inc. |
| Surgical & Medical Instruments & Apparatus |
| Book value per $ invested | $ 0.15 |
| Leverage | 37.65% |
| Market Cap | $ 3.0B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -78.2m |
| Margin | -13.56% |
Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients with venous disease in the United States. The company is headquartered in Irvine, California.